1.      Arbeiter AK, Kranz B, Wingen AM, Bonzel KE, Dohna-Schwake C, Hanssler L, et al. Continuous venovenous haemodialysis (CVVHD) and continuous peritoneal dialysis (CPD) in the acute management of 21 children with inborn errors of metabolism. Nephrol Dial Transplant. 2010;25(4):1257-65. (41)

2.      Baerlocher K, Gitzelmann R, Steinmann B, Gitzelmann-Cumarasamy N. Hereditary fructose intolerance in early childhood: a major diagnostic challenge. Survey of 20 symptomatic cases. Helv Paediatr Acta. 1978;33(6):465-87. (13)

3.      Balakrishnan U. Inborn Errors of Metabolism-Approach to Diagnosis and Management in Neonates. Indian J Pediatr. 2021;88(7):679-89. (1)

4.      Bijarnia-Mahay S, Kapoor S. Testing Modalities for Inborn Errors of Metabolism - What a Clinician Needs to Know? Indian Pediatr. 2019;56(9):757-66. (32)

5.      Brown GK. Glucose transporters: structure, function and consequences of deficiency. J Inherit Metab Dis. 2000;23(3):237-46. (10)

6.      Cecil KM. MR spectroscopy of metabolic disorders. Neuroimaging Clin N Am. 2006;16(1):87-116, viii. (35)

7.      Chace DH, DiPerna JC, Mitchell BL, Sgroi B, Hofman LF, Naylor EW. Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death. Clin Chem. 2001;47(7):1166-82. (26)

8.      Clayton PT, Surtees RA, DeVile C, Hyland K, Heales SJ. Neonatal epileptic encephalopathy. Lancet. 2003;361(9369):1614. (40)

9.      Clayton PT, Winchester BG, Keir G. Hypertrophic obstructive cardiomyopathy in a neonate with the carbohydrate-deficient glycoprotein syndrome. J Inherit Metab Dis. 1992;15(6):857-61. (17)

10.  de Lonlay-Debeney P, Poggi-Travert F, Fournet JC, Sempoux C, Dionisi Vici C, Brunelle F, et al. Clinical features of 52 neonates with hyperinsulinism. N Engl J Med. 1999;340(15):1169-75. (31)

11.  Ellaway CJ, Wilcken B, Christodoulou J. Clinical approach to inborn errors of metabolism presenting in the newborn period. J Paediatr Child Health. 2002;38(5):511-7. (5)

12.  Ficicioglu C, Bearden D. Isolated neonatal seizures: when to suspect inborn errors of metabolism. Pediatr Neurol. 2011;45(5):283-91. (11)

13.  Fries MH, Rinaldo P, Schmidt-Sommerfeld E, Jurecki E, Packman S. Isovaleric acidemia: response to a leucine load after three weeks of supplementation with glycine, L-carnitine, and combined glycine-carnitine therapy. J Pediatr. 1996;129(3):449-52. (39)

14.  Gupta VK, Mishra D, Mathur I, Singh KK. Pyridoxine-dependent seizures: a case report and a critical review of the literature. J Paediatr Child Health. 2001;37(6):592-6. (8)

15.  Haas D, Kelley RI, Hoffmann GF. Inherited disorders of cholesterol biosynthesis. Neuropediatrics. 2001;32(3):113-22. (21)

16.  Häberle J, Boddaert N, Burlina A, Chakrapani A, Dixon M, Huemer M, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet J Rare Dis. 2012;7:32. (34)

17.  Hudak ML, Jones MD, Jr., Brusilow SW. Differentiation of transient hyperammonemia of the newborn and urea cycle enzyme defects by clinical presentation. J Pediatr. 1985;107(5):712-9. (30).

18.  Inborn Metabolic Diseases: Springer; 2022. 906 p. (7)

19.  Krajewska-Walasek M, Gradowska W, Ryzko J, Socha P, Chmielik J, Szapłyko W, et al. Further delineation of the classical Smith-Lemli-Opitz syndrome phenotype at different patient ages: clinical and biochemical studies. Clin Dysmorphol. 1999;8(1):29-40. (22)

20.  Lenke RR, Levy HL. Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies. N Engl J Med. 1980;303(21):1202-8. (23)

21.  Leonard JV, Morris AA. Diagnosis and early management of inborn errors of metabolism presenting around the time of birth. Acta Paediatr. 2006;95(1):6-14. (2)

22.  MacDonald A, Depondt E, Evans S, Daly A, Hendriksz C, Chakrapani AA, et al. Breast feeding in IMD. J Inherit Metab Dis. 2006;29(2-3):299-303. (37)

23.  Mansouri A, Fromenty B, Durand F, Degott C, Bernuau J, Pessayre D. Assessment of the prevalence of genetic metabolic defects in acute fatty liver of pregnancy. J Hepatol. 1996;25(5):781. (28)

24.  Md AN. Neonatal Presentations of Metabolic Disorders. Neoreviews. 2020;21(10):e649-e62. (24)

25.  Morris AA, Taanman JW, Blake J, Cooper JM, Lake BD, Malone M, et al. Liver failure associated with mitochondrial DNA depletion. J Hepatol. 1998;28(4):556-63. (14)

26.  Munnich A, Rustin P. Clinical spectrum and diagnosis of mitochondrial disorders. Am J Med Genet. 2001;106(1):4-17. (20)

27.  Poretti A, Blaser SI, Lequin MH, Fatemi A, Meoded A, Northington FJ, et al. Neonatal neuroimaging findings in inborn errors of metabolism. J Magn Reson Imaging. 2013;37(2):294-312. (36)

28.  Saudubray JM, Garcia-Cazorla À. Inborn Errors of Metabolism Overview: Pathophysiology, Manifestations, Evaluation, and Management. Pediatr Clin North Am. 2018;65(2):179-208. (25)

29.  Saudubray JM, Martin D, de Lonlay P, Touati G, Poggi-Travert F, Bonnet D, et al. Recognition and management of fatty acid oxidation defects: a series of 107 patients. J Inherit Metab Dis. 1999;22(4):488-502. (16)

30.  Saudubray JM, Mochel F, Lamari F, Garcia-Cazorla A. Proposal for a simplified classification of IMD based on a pathophysiological approach: A practical guide for clinicians. J Inherit Metab Dis. 2019;42(4):706-27. (4)

31.  Schaefer F, Straube E, Oh J, Mehls O, Mayatepek E. Dialysis in neonates with inborn errors of metabolism. Nephrol Dial Transplant. 1999;14(4):910-8. (42)

32.  Shanmugam NP, Bansal S, Greenough A, Verma A, Dhawan A. Neonatal liver failure: aetiologies and management--state of the art. Eur J Pediatr. 2011;170(5):573-81. (12)

33.  Spiekerkoetter U, Lindner M, Santer R, Grotzke M, Baumgartner MR, Boehles H, et al. Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop. J Inherit Metab Dis. 2009;32(4):498-505. (38)

34.  Topcu M, Coskun T, Haliloglu G, Saatci I. Molybdenum cofactor deficiency: report of three cases presenting as hypoxic-ischemic encephalopathy. J Child Neurol. 2001;16(4):264-70. (6)

35.  Torres OA, Miller VS, Buist NM, Hyland K. Folinic acid-responsive neonatal seizures. J Child Neurol. 1999;14(8):529-32. (9)

36.  van den Hout HM, Hop W, van Diggelen OP, Smeitink JA, Smit GP, Poll-The BT, et al. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics. 2003;112(2):332-40. (18)

37.  van Karnebeek CD, Houben RF, Lafek M, Giannasi W, Stockler S. The treatable intellectual disability APP www.treatable-id.org: a digital tool to enhance diagnosis & care for rare diseases. Orphanet J Rare Dis. 2012;7:47. (3)

38.  von der Hagen M, Pivarcsi M, Liebe J, von Bernuth H, Didonato N, Hennermann JB, et al. Diagnostic approach to microcephaly in childhood: a two-center study and review of the literature. Dev Med Child Neurol. 2014;56(8):732-41. (19)

39.  Weinstein DA, Steuerwald U, De Souza CFM, Derks TGJ. Inborn Errors of Metabolism with Hypoglycemia: Glycogen Storage Diseases and Inherited Disorders of Gluconeogenesis. Pediatr Clin North Am. 2018;65(2):247-65. (15)

40.  Wertheim-Tysarowska K, Gos M, Sykut-Cegielska J, Bal J. Genetic analysis in inherited metabolic disorders--from diagnosis to treatment. Own experience, current state of knowledge and perspectives. Dev Period Med. 2015;19(4):413-31. (33)

41.  Wilcken B, Leung KC, Hammond J, Kamath R, Leonard JV. Pregnancy and fetal long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency. Lancet. 1993;341(8842):407-8. (27)

42.  Wraith JE. Ornithine carbamoyltransferase deficiency. Arch Dis Child. 2001;84(1):84-8. (29)